Zylox-Tonbridge Medical Technology Co., Ltd. (2190.HK)
HKD 11.12
(0.18%)
HKD 11.12
(0.18%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 541.51 Million CNY | 11.49% |
| 2022 | 474.85 Million CNY | 35.7% |
| 2021 | 349.93 Million CNY | 206.77% |
| 2020 | 114.07 Million CNY | 62.64% |
| 2019 | 70.13 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 112.15 Million CNY | 0.0% |
| 2024 Q1 | 112.15 Million CNY | -24.41% |
| 2023 FY | 529.42 Million CNY | 11.49% |
| 2023 Q2 | 122.38 Million CNY | 0.0% |
| 2023 Q4 | 148.36 Million CNY | 0.0% |
| 2023 Q1 | 122.38 Million CNY | -13.88% |
| 2023 Q3 | 148.36 Million CNY | 21.22% |
| 2022 Q2 | 88.42 Million CNY | 0.0% |
| 2022 FY | 474.85 Million CNY | 35.7% |
| 2022 Q3 | 142.1 Million CNY | 60.71% |
| 2022 Q1 | 88.42 Million CNY | -19.73% |
| 2022 Q4 | 142.1 Million CNY | 0.0% |
| 2021 Q3 | 110.15 Million CNY | 77.62% |
| 2021 Q2 | 62.01 Million CNY | 0.0% |
| 2021 FY | 349.93 Million CNY | 206.77% |
| 2021 Q4 | 110.15 Million CNY | 0.0% |
| 2021 Q1 | 62.01 Million CNY | 52.31% |
| 2020 FY | 114.07 Million CNY | 62.64% |
| 2020 Q3 | 40.71 Million CNY | 132.6% |
| 2020 Q1 | 17.5 Million CNY | 0.0% |
| 2020 Q2 | 17.5 Million CNY | 0.0% |
| 2020 Q4 | 40.71 Million CNY | 0.0% |
| 2019 FY | 70.13 Million CNY | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Vincent Medical Holdings Limited | 174.6 Million HKD | -210.131% |